| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Cytarabine | CTRPv2 | pan-cancer | AAC | -0.14 | 9e-07 |
| mRNA | PD-0325901 | gCSI | pan-cancer | AAC | 0.25 | 2e-06 |
| mRNA | CCT018159 | GDSC1000 | pan-cancer | AAC | 0.16 | 5e-06 |
| mRNA | pac-1 | CTRPv2 | pan-cancer | AAC | -0.16 | 1e-05 |
| mRNA | GMX-1778 | CTRPv2 | pan-cancer | AAC | -0.16 | 2e-05 |
| mRNA | Oxaliplatin | CTRPv2 | pan-cancer | AAC | -0.14 | 2e-05 |
| mRNA | ISOX:bortezomib (250:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.15 | 2e-05 |
| mRNA | I-BET151 | CTRPv2 | pan-cancer | AAC | -0.13 | 3e-05 |
| mRNA | TAE684 | GDSC1000 | pan-cancer | AAC | 0.22 | 4e-05 |
| mRNA | 17-AAG | GDSC1000 | pan-cancer | AAC | 0.13 | 6e-05 |